Advertisement
Screener

SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Assets, Accumulated Amortization

SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Assets, Accumulated Amortization

SALIX PHARMACEUTICALS LTD had Finite-Lived Intangible Assets, Accumulated Amortization of -$365.55 million as of 2014-12-31, per its 10-K filed 2015-03-02.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2015-03-02

  • 2014-12-31: Finite-Lived Intangible Assets, Accumulated Amortization -$365.55M.
  • 2014-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $311.18M; Finite-Lived Intangible Assets, Accumulated Amortization as first filed $314.17M.
  • 2014-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $257.08M; Finite-Lived Intangible Assets, Accumulated Amortization as first filed $259.08M.
  • 2014-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $203.44M; Finite-Lived Intangible Assets, Accumulated Amortization as first filed $204.44M.
Period endFinite-Lived Intangible Assets, Accumulated AmortizationFinite-Lived Intangible Assets, Accumulated Amortization as first filed
2014-12-31-$365.55M
10-K · filed 2015-03-02
2014-09-30$311.18M
10-Q/A · filed 2015-03-02
$314.17M
10-Q · filed 2014-11-07
2014-06-30$257.08M
10-Q/A · filed 2015-03-02
$259.08M
10-Q · filed 2014-08-08
2014-03-31$203.44M
10-Q/A · filed 2015-03-02
$204.44M
10-Q · filed 2014-05-09
2013-12-31$149.32M
10-K · filed 2015-03-02
2013-09-30$137.98M
10-Q · filed 2013-11-08
2013-06-30$126.79M
10-Q · filed 2013-08-09
2013-03-31$115.63M
10-Q · filed 2013-05-10
2012-12-31$104.68M
10-K · filed 2015-03-02
2012-09-30$93.36M
10-Q · filed 2012-11-08
2012-06-30$82.02M
10-Q · filed 2012-08-09
2012-03-31$70.67M
10-Q · filed 2012-05-08
2011-12-31$59.33M
10-K · filed 2013-03-01
2011-09-30$56.44M
10-Q · filed 2011-11-09
2011-06-30$53.55M
10-Q · filed 2011-08-09
2010-12-31$48.42M
10-K · filed 2012-02-28